For those following the proceeding between AbbVie and Jansen relating to Stelara, the Court docket indicates a settlement was reached and today the Court issued an order that all claims and counterclaims be dismissed with prejudice. In October, the Federal Court of Appeal had set aside the trial decision and ordered a new trial.

Some of the decisions on the proceeding, T-1310-09 (Stelara/Ustekinumab) were:

See my earlier post on this proceeding when the trial decision was issued in January 2014.